GGrantIndex
Sort

59,101 grants matching hypertension

A-Adrenergic Axis in Hypertrophy and Heart Failure

$596,796
Gerald W. Dorn · University Of Cincinnati · P50 · FY2006 · HL

Tailored Case Management for Diabetes and Hypertension

$596,745
David Edelman · Duke University · R01 · FY2012 · DK

ACES - ACE inhibitors Combined with Exercise for hypertensive Seniors

$596,690
Thomas W Buford · University Of Alabama At Birmingham · R01 · FY2018 · AG

Novel role of smooth muscle B5 reductase in Sickle Cell Disease

$596,648
Adam Carl Straub · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · HL

Data Coordinating Center for Pilot Studies of Candidate Therapies for CKD

$596,629
Jennifer J. Gassman · Cleveland Clinic Lerner Com-Cwru · U01 · FY2014 · DK

Modeling Tyrosine Kinase Inhibitor-Induced Vascular Dysfunction Using Human iPSCs

$596,600
Joseph C Wu · Stanford University · R01 · FY2018 · HL

GENE REGULATION BY STEROID RECEPTOR PROTEINS

$596,593
University Of California San Francisco · R01 · FY2000 · CA

The Injectrode- An injectable, easily removable electrode as a trial lead for baroreceptor activation therapy to treat hypertension and heart failure

$596,582
Manfred Franke · Neuronoff, Inc. · R43 · FY2023 · HL

Application of Implementation Science approaches to assess the effectiveness of Task-shifted WHO-PEN to address cardio metabolic complications in people living with HIV in Zambia

$596,565
Wilbroad Mutale · Centre For Infectious Disease Research · UH3 · FY2023 · HL

Per- and Polyfluoroalkyl substances mixtures and maternal cardiovascular disease risk across the reproductive life course

$596,523
Tamarra M James-Todd · Harvard University D/B/A Harvard School Of Public Health · R01 · FY2024 · ES

Multi-scale Investigation of Sex Differences in Right Ventricular Function via Estrogen-Microtubule Interactions

$596,499
Kurt W Prins · University Of Minnesota · R01 · FY2024 · HL

Discovery Approach to Ocular Hypertension

$596,485
M. Elizabeth Fini · University Of Southern California · R01 · FY2017 · EY

GENE REGULATION BY STEROID RECEPTOR PROTEINS

$596,476
Keith Robert Yamamoto · University Of California, San Francisco · R01 · FY2009 · CA

Genetics of childhood-onset hypertension

$596,455
Neil Hanchard · National Human Genome Research Institute · ZIA · FY2024 · HG

ESOPHAGEAL VARICES BY B-ADRENERGIC BLOCKERS

$596,414
Yale University · R01 · FY2000 · DK

Dietary Patterns and Risk of Cardiovascular Disease

$596,354
Frank B Hu · Harvard School Of Public Health · R01 · FY2013 · HL

Targeting Resident Cardiac Fibroblast Subpopulations for Protection Against Fibrosis

$596,239
Taben M. Hale · University Of Arizona · R01 · FY2023 · HL

Medicare Study of Cost-sharing Ramifications and Prescription Drug Benefits

$596,229
John Hsu · Kaiser Foundation Research Institute · R01 · FY2007 · AG

Ion Channel Screening Using Photoswitches

$596,204
Andrew Blatz · Photoswitch Biosciences, Inc. · R44 · FY2014 · GM

Sleep Restriction and Augmented Vascular Risk in Prehypertension

$596,174
Virend K Somers · Mayo Clinic Rochester · R01 · FY2014 · HL

Applying Hypertension Clinical Trials to Real World Adults with CKD

$596,163
Manjula Kurella Tamura · Palo Alto Veterans Instit For Research · R01 · FY2025 · DK

Exome Variants Underlying Weight Gain from Adolescence to Adulthood

$596,111
Penny Gordon-Larsen · Univ Of North Carolina Chapel Hill · R01 · FY2016 · HD

Experimental and computational analysis of mechanisms of mitochondrial-cellular ROS crosstalk in the kidney in salt-sensitive hypertension

$596,109
Allen W Cowley · Medical College Of Wisconsin · R01 · FY2024 · HL

A Personalized Metabolomic Approach to Human Obesity and Weight Loss

$596,091
Svati H. Shah · Duke University · R01 · FY2017 · HL

Metabolic Function in Pulmonarv Vascular Disease/Loyd

$596,060
John Hughes Newman · Vanderbilt University · P01 · FY2015 · HL